about
The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cellsClass I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivoNext-generation sequencing: hype and hope for development of personalized radiation therapy?Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinomaFibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer.Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survival.Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancerLoss of BAP1 Expression Occurs Frequently in Intrahepatic CholangiocarcinomaWould Virchow be a systems biologist? A discourse on the philosophy of science with implications for pathological research.Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells.Comprehensive analysis of clinico-pathological data reveals heterogeneous relations between atherosclerosis and cancer.High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo.Ioncopy: a novel method for calling copy number alterations in amplicon sequencing data including significance assessment.Who is at risk for diagnostic discrepancies? Comparison of pre- and postmortal diagnoses in 1800 patients of 3 medical decades in East and West Berlin.Clinical and molecular characteristics of HNSCC patients with brain metastases: a retrospective study.A new classification method for MALDI imaging mass spectrometry data acquired on formalin-fixed paraffin-embedded tissue samples.Fungi and inflammatory bowel diseases: Alterations of composition and diversity.A prognostic gene expression index in ovarian cancer - validation across different independent data sets.Vascular CXCR4 expression - a novel antiangiogenic target in gastric cancer?Genotypic and phenotypic characterization of side population of gastric cancer cell lines.Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts.Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas.Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas.Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis.Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes.RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab.Combination of phage display and molecular grafting generates highly specific tumor-targeting miniproteins.Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patientsMutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences.Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression.Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing.Mutations in POLE and survival of colorectal cancer patients--link to disease stage and treatment.The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.Association of angiogenic factors with prognosis in esophageal cancer.The landscape of metastatic progression patterns across major human cancers
P50
Q24305557-FD9C1E8B-0AEE-463E-97BA-1E79068C63FAQ24312156-23339F0B-EDF9-4D3D-BFE7-88F9D71EF685Q26796485-A58992B9-610F-413B-95CC-F38021A621B7Q27851653-81B12FDB-A95D-44BE-AA81-A324C37612BEQ27852569-6FA049D8-89FD-49F8-8CE8-D58EEA968E75Q27852581-2D287C2A-9740-454F-8995-29C321303749Q27853096-5EBB2F2E-C218-48D9-8D08-C11B78F4FC46Q27853287-18505F0C-FA79-4DFC-B5DD-57261DEAEE07Q28257189-BB4DC2EF-27BD-458D-A935-8D58D9967303Q28384496-85C09E07-9B1E-4506-9E13-53A7D7B9E49EQ30388571-6AAF33AC-A52C-4DBB-84C6-D19D386A7361Q30637438-E69176C9-79BF-4D51-A086-14FD417208E1Q30755617-D646BD27-F053-49D7-87BE-F1224B774820Q30884835-2CB94AD7-E45A-4CFF-AB42-0ED10907DF36Q31048851-19CC027A-DC1B-488B-80D5-EAF873DF1CBBQ31062556-95C19E88-39A2-44A3-B78A-A1A1208BDDFEQ31127773-CBF80763-0949-4354-B4C4-2E527C929B73Q31141990-4AD59015-353B-42E7-81E3-EFA75E02DB5EQ33347197-5CAC1E86-075D-4CEE-92B7-D4026FB9ACA8Q33419209-B21CAD37-8FCF-4DA7-815C-373A91DBB6DFQ33553482-F418CFB8-5200-408D-B141-B05D57005E79Q33855045-A8D9F703-065C-45B9-A617-5CC276220BF4Q33863533-758811B8-C6DB-4932-9FAF-AD452C75BAD1Q33942343-08A3744A-E933-4A25-A988-C1E3CA292036Q33960748-C152E935-99C0-4EE7-9E67-61646ADD438DQ34191150-358313AF-77F7-457F-873E-C89EACCD9EF6Q34203176-30B18024-E9CB-4173-ADAC-75EE90251DEDQ34227741-4637B240-FFF7-4205-BC4C-233A0088ED10Q34276961-5D917229-7476-4AAE-B69F-21BD791AB3ABQ34331751-33712F50-A025-42A3-A4DD-7B4143D9984FQ34476250-0DB42415-2C03-4A37-9DC3-364933EAAE3EQ34483478-81864096-6670-4EC0-9189-0A0FC7BDE470Q34654793-57D54A30-BF92-42B0-950F-C3C07E85567DQ34693969-CD5460AD-1C4E-4CB5-80AA-9D96C13719A3Q34756429-DAAE3746-1153-459D-8225-17451D257287Q34968668-C0E2E2DD-7A09-4F1F-AD05-32814637B0C3Q34982562-BA5E43DF-0375-4339-AF94-5C32EE34AC40Q35043569-6E26CFDD-F0EF-4652-A253-83E39C651AB3Q35185524-33B63910-A438-47E3-BFFD-E95565D015E2Q35238521-E38CD4FF-4B91-4742-B824-71DE36AE3135
P50
description
onderzoeker
@nl
name
Wilko Weichert
@ast
Wilko Weichert
@en
Wilko Weichert
@es
Wilko Weichert
@sl
type
label
Wilko Weichert
@ast
Wilko Weichert
@en
Wilko Weichert
@es
Wilko Weichert
@sl
prefLabel
Wilko Weichert
@ast
Wilko Weichert
@en
Wilko Weichert
@es
Wilko Weichert
@sl